PL3257511T3 - Tabletka rozpadająca się w jamie ustnej i sposób jej wytwarzania - Google Patents

Tabletka rozpadająca się w jamie ustnej i sposób jej wytwarzania

Info

Publication number
PL3257511T3
PL3257511T3 PL15882014T PL15882014T PL3257511T3 PL 3257511 T3 PL3257511 T3 PL 3257511T3 PL 15882014 T PL15882014 T PL 15882014T PL 15882014 T PL15882014 T PL 15882014T PL 3257511 T3 PL3257511 T3 PL 3257511T3
Authority
PL
Poland
Prior art keywords
orally disintegrating
disintegrating tablet
manufacturing same
tablet
orally
Prior art date
Application number
PL15882014T
Other languages
English (en)
Inventor
Kotaro Okada
Hisahiro Mori
Shigetomo Tsujihata
Yoshinori Sakata
Original Assignee
Fujifilm Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corporation filed Critical Fujifilm Corporation
Publication of PL3257511T3 publication Critical patent/PL3257511T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL15882014T 2015-02-10 2015-09-10 Tabletka rozpadająca się w jamie ustnej i sposób jej wytwarzania PL3257511T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2015024699 2015-02-10
JP2015140608 2015-07-14
EP15882014.2A EP3257511B1 (en) 2015-02-10 2015-09-10 Orally disintegrating tablet and method for manufacturing same
PCT/JP2015/075749 WO2016129140A1 (ja) 2015-02-10 2015-09-10 口腔内崩壊錠及びその製造方法

Publications (1)

Publication Number Publication Date
PL3257511T3 true PL3257511T3 (pl) 2019-03-29

Family

ID=56614591

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15882014T PL3257511T3 (pl) 2015-02-10 2015-09-10 Tabletka rozpadająca się w jamie ustnej i sposób jej wytwarzania

Country Status (7)

Country Link
US (1) US20170304196A1 (pl)
EP (1) EP3257511B1 (pl)
JP (2) JP6371866B2 (pl)
DK (1) DK3257511T3 (pl)
ES (1) ES2700364T3 (pl)
PL (1) PL3257511T3 (pl)
WO (1) WO2016129140A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6946029B2 (ja) * 2016-03-30 2021-10-06 エスエス製薬株式会社 経口用医薬組成物
CN111655770A (zh) * 2017-12-01 2020-09-11 电缆元件集团有限责任公司 用于制造泡沫制品的可发泡的组合物和方法
WO2019131891A1 (ja) * 2017-12-28 2019-07-04 大日本住友製薬株式会社 苦味がマスキングされた薬物含有粒子及び該薬物含有粒子を含む製剤
CN110013467B (zh) * 2018-01-10 2021-09-17 上海汉都医药科技有限公司 一种固体微粒及其制备方法和含其的药物组合物
WO2020071539A1 (ja) * 2018-10-05 2020-04-09 富士化学工業株式会社 多孔性シリカ粒子組成物
JP2024007006A (ja) * 2022-07-05 2024-01-18 共和薬品工業株式会社 ベンラファキシン塩酸塩含有顆粒及びその製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1452177A (en) * 1920-04-02 1923-04-17 Aragose Frank Spark plug
JPS5176413A (ja) * 1974-12-25 1976-07-02 Toyo Jozo Kk Hifukuzainoseizoho
JP2000119198A (ja) * 1998-10-16 2000-04-25 Eisai Co Ltd 苦味等の隠蔽されたホスフォジエステラーゼ阻害剤含有経口製剤
EP1452177A1 (en) * 2003-02-27 2004-09-01 Boehringer Ingelheim International GmbH Pharmaceutical formulations comprising sodium laurylsulfate as bitterness masking agent
EP2040676A2 (en) * 2006-07-06 2009-04-01 Forest Laboratories, Inc. Orally dissolving formulations of memantine
EP2254556A2 (en) * 2008-03-11 2010-12-01 Takeda Pharmaceutical Company Limited Orally-disintegrating solid preparation
JPWO2011062194A1 (ja) * 2009-11-18 2013-04-04 武田薬品工業株式会社 アミノピリジン誘導体
JP5680898B2 (ja) * 2010-08-10 2015-03-04 京都薬品工業株式会社 苦味を抑制した速崩壊錠
JP2012056909A (ja) * 2010-09-10 2012-03-22 Fuji Chem Ind Co Ltd 苦味薬物の苦味を低減した医薬組成物
RU2503447C1 (ru) * 2012-11-20 2014-01-10 Максим Эдуардович Запольский Лекарственное средство в форме ородисперсной таблетки и способ получения лекарственного средства

Also Published As

Publication number Publication date
WO2016129140A1 (ja) 2016-08-18
JP6371866B2 (ja) 2018-08-08
JP6628840B2 (ja) 2020-01-15
EP3257511A4 (en) 2018-01-24
ES2700364T3 (es) 2019-02-15
JP2018150384A (ja) 2018-09-27
EP3257511B1 (en) 2018-10-24
JPWO2016129140A1 (ja) 2017-06-29
EP3257511A1 (en) 2017-12-20
DK3257511T3 (en) 2019-01-21
US20170304196A1 (en) 2017-10-26

Similar Documents

Publication Publication Date Title
GB201509751D0 (en) Tablet case and method of manufacture
EP3135394A4 (en) Method for manufacturing hot press forming part and hot press forming part
EP3219671A4 (en) Aerogel and manufacturing method thereof
IL327430A (en) Ribociclib tablet
SG11201801027SA (en) Apparatus and manufacturing method
IL262312A (en) Disintegrating tablets for oral administration
SG10201914087UA (en) Tablet
GB2591026B (en) Improvements in tablet manufacture
GB2560293B (en) Biochip and method for manufacturing biochip
PT3449912T (pt) Comprimido de desintegração por via oral
GB2557762B (en) Thru-casing section mill
GB2555956B (en) A cabinet and method for manufacturing a cabinet
PT3446684T (pt) Comprimido orodispersível
GB201501603D0 (en) Method and product
GB201507581D0 (en) Method
EP3257511A4 (en) Intraoral rapid disintegration tablet and method for manufacturing same
EP3270900A4 (en) Carbohydrate tablet and method of fabrication
SG11201810789WA (en) Case and method for producing case
EP3369548A4 (en) Case and method for producing case
TWI562884B (en) Manufacturing method and manufacturing system
ZA201704553B (en) Recess plate and method for manufacturing the same
PL3238712T3 (pl) Tabletka ulegająca bardzo szybkiemu rozpadowi i sposób jej wytwarzania
GB201511252D0 (en) Tablet
GB201506480D0 (en) Manufacturing method and apparatus
GB201508784D0 (en) Manufacturing method